Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift

Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift

Brain metastases (BMs) are common among patients affected by HER2+ metastatic breast cancer (>30%). The management of BMs is usually multimodal, including surgery, radiotherapy, systemic therapy and palliative care. Standard brain radiotherapy (RT) includes the use of stereotactic radiotherapy (S...

Full description

Bibliographic Details
Main Authors: Edy Ippolito, Sonia Silipigni, Paolo Matteucci, Carlo Greco, Sofia Carrafiello, Vincenzo Palumbo, Claudia Tacconi, Claudia Talocco, Michele Fiore, Rolando Maria D’Angelillo, Sara Ramella
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
brain metastases
stereotactic radiotherapy
HER2+
multimodal treatment
radiosensitization
side effects
Online Access:https://www.mdpi.com/2072-6694/14/6/1514

Internet

https://www.mdpi.com/2072-6694/14/6/1514

Similar Items